A Global Phase 2b, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ninerafaxstat in Patients with Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy – FORTITUDE-HCM (IMB101-010 (FORTITUDE-HCM))

Principal Investigator

Dr Betty Raman

Contact us

Email: cvm_nurses@cardiov.ox.ac.uk

IRAS number

1012709